Chevy Chase Trust’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-37,854
Closed -$21K – 687
2016
Q3
$21K Hold
37,854
– – ﹤0.01% 650
2016
Q2
$22K Hold
37,854
– – ﹤0.01% 647
2016
Q1
$55K Buy
37,854
+989
+3% +$1.95K ﹤0.01% 649
2015
Q4
$118K Hold
36,865
– – ﹤0.01% 650
2015
Q3
$230K Hold
36,865
– – ﹤0.01% 628
2015
Q2
$366K Hold
36,865
– – ﹤0.01% 603
2015
Q1
$272K Hold
36,865
– – ﹤0.01% 625
2014
Q4
$197K Hold
36,865
– – ﹤0.01% 673
2014
Q3
$185K Hold
36,865
– – ﹤0.01% 678
2014
Q2
$247K Hold
36,865
– – ﹤0.01% 649
2014
Q1
$267K Hold
36,865
– – ﹤0.01% 632
2013
Q4
$139K Buy
+36,865
New +$143K ﹤0.01% 639

Other funds holding NWBO

Chevy Chase Trust's NWBO Position: Q4 2016 in Review

Chevy Chase Trust sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 37,854 shares — an estimated $21K sold.

Chevy Chase Trust first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $366K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Chevy Chase Trust reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
  • Chevy Chase Trust sold 37,854 Northwest Biotherapeutics shares in Q4 2016, an estimated $21K.
  • Chevy Chase Trust first reported a position in Northwest Biotherapeutics in Q4 2013 and held it in 12 quarters.
  • Chevy Chase Trust's Northwest Biotherapeutics position peaked at $366K in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.

Based on Chevy Chase Trust's 13F filing for Q4 2016, filed 9 Jan 2017.